Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001548123-13-000077
Filing Date
2013-03-27
Accepted
2013-03-27 16:29:56
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED DECEMBER 31, 2012 skin_201210k4.htm 10-K 400902
2 PRINCIPAL EXECUTIVE OFFICER ex311.htm EX-31 5971
3 PRINCIPAL FINANCIAL OFFICER ex312.htm EX-31 5965
4 SECTION 1350 CERTIFICATION ex32.htm EX-32 3162
  Complete submission text file 0001548123-13-000077.txt   1862562

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT skin-20121231.xml EX-101.INS 216898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skin-20121231_pre.xml EX-101.PRE 86511
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skin-20121231_lab.xml EX-101.LAB 102914
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skin-20121231_def.xml EX-101.DEF 66423
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skin-20121231_cal.xml EX-101.CAL 17850
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skin-20121231.xsd EX-101.SCH 17004
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30991 | Film No.: 13720324
SIC: 6770 Blank Checks